 |
Products |  |
Diseases | | Products |
|
Trials |  |
News |  |
- | cannabiol (KL16-012) / Knop Laboratorios
New P2 trial: Phase II Clinical Trial, Use of KL16-012 in Women With Fibromyalgia Refractary to Conventional Treatment. (clinicaltrials.gov) - Jan 27, 2020
P2, N=44, Not yet recruiting, Sponsor: Knop Laboratorios